Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself-Reference-Cited by-同舟云学术

Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself

Published:2020-04-24 Issue:3 Volume:23 Page:279-298
ISSN:0969-6970
Container-title:Angiogenesis
language:en
Short-container-title:Angiogenesis

Author:

Yang Qian-Kun,Chen Tong,Wang Shi-Qi,Zhang Xiao-Jing,Yao Zhong-Xiang^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Biochemistry,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10456-020-09716-y.pdf

Reference148 articles.

1. Burningham Z, Hashibe M, Spector L, Schiffman JD (2012) The epidemiology of sarcoma. Clin Sarcoma Res 2(1):14

2. Jo VY, Doyle LA (2016) Refinements in sarcoma classification in the current 2013 world health organization classification of tumours of soft tissue and bone. Surg Oncol Clin N Am 25(4):621–643

3. Crago AM, Brennan MF (2015) Principles in management of soft tissue sarcoma. Adv Surg 49:107–122

4. Ferguson JL, Turner SP (2018) Bone cancer: diagnosis and treatment principles. Am Fam Phys 98(4):205–213

5. Aggerholm-Pedersen N, Rossen P, Rose H, Safwat A (2019) Pazopanib in the treatment of bone sarcomas: clinical experience. Transl Oncol 13(2):295–299

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma;Cancer Medicine;2024-07

2. A study protocol for an open‐label, single‐arm, single‐center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma;Thoracic Cancer;2024-01-11

3. Molecularly Engineered Room-Temperature Phosphorescence for Biomedical Application: From the Visible toward Second Near-Infrared Window;Chemical Reviews;2023-11-22

4. Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study;Frontiers in Oncology;2023-11-13

5. Tumor microenvironment diversity and plasticity in cancer multidrug resistance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11